Copyright
©The Author(s) 2019.
World J Gastroenterol. Nov 21, 2019; 25(43): 6386-6403
Published online Nov 21, 2019. doi: 10.3748/wjg.v25.i43.6386
Published online Nov 21, 2019. doi: 10.3748/wjg.v25.i43.6386
Figure 3 Ubiquitin-conjugating enzyme E2T reduction inhibits the xenograft tumor growth of SMMC-7721 cells.
A: Representative images of xenograft tumors derived from nude mice implanted with ShCtrl and ShUBE2T SMMC-7721 cells. n = 8 per group; B: Xenograft tumor growth in nude mice implanted with ShCtrl and ShUBE2T SMMC-7721 cells from day 13 to 42. n = 8 per group. aP < 0.05, bP < 0.01, cP < 0.001; C: ShCtrl and ShUBE2T xenograft tumor weight 42 d after implantation. bP < 0.01.
- Citation: Guo J, Wang M, Wang JP, Wu CX. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis via inducing cell cycle arrest and apoptosis. World J Gastroenterol 2019; 25(43): 6386-6403
- URL: https://www.wjgnet.com/1007-9327/full/v25/i43/6386.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i43.6386